blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2164828

EP2164828 - COMPOUNDS AS CRTH2 AND/OR PGD2 RECEPTORS MODULATORS AND THEIR USE FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.01.2014
Database last updated on 14.11.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU
published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2010/12]
Inventor(s)01 / BROWN, Matthew
638 Minna Street, Apt. 7
San Francisco, CA 94103 / US
02 / JOHNSON, Michael, G.
409 Clipper Street
San Francisco, CA 94114 / US
03 / LI, An-Rong
1656B Marina Court
San Mateo, CA 94403 / US
04 / LIU, Jiwen
721 Celestial Lane
Foster City, CA 94404 / US
05 / LIVELY, Sarah, E.
1536 Eaton Avenue
San Carlos, CA 94070 / US
06 / MEDINA, Julio, C.
1407 Cedar Street
San Carlos, CA 94070 / US
07 / SHEN, Wang
1719 Monticello Road
San Mateo, CA 94402 / US
08 / WANG, Xuemei
5134 Shelter Creek Lane
San Bruno, CA 94066 / US
09 / WANG, Yingcai
33924 Capulet Circle
Fremont, CA 94555 / US
 [2010/12]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2013/13]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2010/12]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Application number, filing date08743426.201.05.2008
[2010/12]
WO2008US05611
Priority number, dateUS20070927545P02.05.2007         Original published format: US 927545 P
[2010/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008137027
Date:13.11.2008
Language:EN
[2008/46]
Type: A2 Application without search report 
No.:EP2164828
Date:24.03.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 13.11.2008 takes the place of the publication of the European patent application.
[2010/12]
Type: B1 Patent specification 
No.:EP2164828
Date:27.03.2013
Language:EN
[2013/13]
Search report(s)International search report - published on:EP15.01.2009
ClassificationIPC:C07D209/08, C07D209/34, C07D209/42, C07D209/48, C07D215/38, C07D231/56, C07D235/08, C07D277/82, C07D471/04, C07D215/227, A61P11/06, A61P37/08, A61P17/06
[2010/12]
CPC:
C07D209/08 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P11/00 (EP); A61P11/02 (EP); A61P11/06 (EP);
A61P17/00 (EP); A61P17/04 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P29/02 (EP);
A61P3/00 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P35/00 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P9/10 (EP); C07D209/10 (EP,US);
C07D209/34 (EP,US); C07D209/42 (EP,US); C07D209/48 (EP,US);
C07D213/68 (EP,US); C07D213/76 (EP,US); C07D215/38 (EP,US);
C07D231/56 (EP,US); C07D235/08 (EP,US); C07D235/22 (EP,US);
C07D277/82 (EP,US); C07D405/12 (EP,US); C07D471/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/12]
Extension statesAL01.12.2009
BA01.12.2009
MK01.12.2009
RS01.12.2009
TitleGerman:CRTH2 UND/ODER PGD2 REZEPTOR-MODULATOREN UND DEREN VERWENDUNG ZUR BEHANDLUNG VON ASTHMA UND ALLERGISCHER ENTZÜNDUNGEN.[2010/12]
English:COMPOUNDS AS CRTH2 AND/OR PGD2 RECEPTORS MODULATORS AND THEIR USE FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION[2010/12]
French:MODULATEURS DES RÉCEPTEURS CRTH2 ET OU PGD2 ET LEUR EMPLOI POUR TRAITER L'ASTHME ET LES INFLAMMATIONS D'ORIGINE ALLERGIQUE[2010/12]
Entry into regional phase01.12.2009National basic fee paid 
01.12.2009Designation fee(s) paid 
01.12.2009Examination fee paid 
Examination procedure01.12.2009Amendment by applicant (claims and/or description)
01.12.2009Examination requested  [2010/12]
31.03.2010Despatch of a communication from the examining division (Time limit: M04)
07.05.2010Reply to a communication from the examining division
11.04.2011Despatch of a communication from the examining division (Time limit: M06)
14.10.2011Reply to a communication from the examining division
06.11.2012Communication of intention to grant the patent
14.02.2013Fee for grant paid
14.02.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.03.2010
Opposition(s)03.01.2014No opposition filed within time limit [2014/10]
Fees paidRenewal fee
31.03.2010Renewal fee patent year 03
11.05.2011Renewal fee patent year 04
30.03.2012Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.05.2008
AT27.03.2013
BE27.03.2013
CY27.03.2013
CZ27.03.2013
DK27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
MC27.03.2013
MT27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
TR27.03.2013
IE01.05.2013
LU01.05.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
[2015/34]
Former [2015/32]AT27.03.2013
BE27.03.2013
CY27.03.2013
CZ27.03.2013
DK27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
MC27.03.2013
MT27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
TR27.03.2013
IE01.05.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2015/13]AT27.03.2013
BE27.03.2013
CY27.03.2013
CZ27.03.2013
DK27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
MC27.03.2013
MT27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
IE01.05.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2014/20]AT27.03.2013
BE27.03.2013
CY27.03.2013
CZ27.03.2013
DK27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
MC27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
IE01.05.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2014/09]AT27.03.2013
BE27.03.2013
CY27.03.2013
CZ27.03.2013
DK27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
MC27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2014/03]AT27.03.2013
BE27.03.2013
CY27.03.2013
CZ27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
MC27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2013/52]AT27.03.2013
BE27.03.2013
CY27.03.2013
CZ27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2013/50]AT27.03.2013
BE27.03.2013
CZ27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
NL27.03.2013
PL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2013/49]AT27.03.2013
BE27.03.2013
CZ27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
NL27.03.2013
RO27.03.2013
SE27.03.2013
SI27.03.2013
SK27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2013/48]AT27.03.2013
BE27.03.2013
EE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
NL27.03.2013
SE27.03.2013
SI27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
IS27.07.2013
PT29.07.2013
Former [2013/47]BE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
SE27.03.2013
SI27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
PT29.07.2013
Former [2013/44]BE27.03.2013
FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
SE27.03.2013
SI27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
Former [2013/41]FI27.03.2013
HR27.03.2013
LT27.03.2013
LV27.03.2013
SE27.03.2013
SI27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
Former [2013/38]FI27.03.2013
LT27.03.2013
LV27.03.2013
SE27.03.2013
SI27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
Former [2013/37]FI27.03.2013
LT27.03.2013
SE27.03.2013
SI27.03.2013
BG27.06.2013
NO27.06.2013
GR28.06.2013
Former [2013/34]LT27.03.2013
SE27.03.2013
BG27.06.2013
NO27.06.2013
Former [2013/33]LT27.03.2013
NO27.06.2013
Cited inInternational search[Y]WO2004058164  (TULARIK INC [US]) [Y] 1-12,14-28 * examples;;; claims 1,21,25,27,31 *;
 [Y]WO9533461  (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-12,14-28 * claims 1,13-15 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.